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Background: Pseudogenes are traditionally considered “dead” genes, therefore lacking biological functions. This
view has however been challenged during the last decade. This is the case of the Protein phosphatase 1 regulatory
subunit 2 (PPP1R2) or inhibitor-2 gene family, for which several incomplete copies exist scattered throughout the
genome.
Results: In this study, the pseudogenization process of PPP1R2 was analyzed. Ten PPP1R2-related pseudogenes
(PPP1R2P1-P10), highly similar to PPP1R2, were retrieved from the human genome assembly present in the
databases. The phylogenetic analysis of mammalian PPP1R2 and related pseudogenes suggested that PPP1R2P7
and PPP1R2P9 retroposons appeared before the great mammalian radiation, while the remaining pseudogenes are
primate-specific and retroposed at different times during Primate evolution. Although considered inactive, four of
these pseudogenes seem to be transcribed and possibly possess biological functions. Given the role of PPP1R2 in
sperm motility, the presence of these proteins was assessed in human sperm, and two PPP1R2-related proteins
were detected, PPP1R2P3 and PPP1R2P9. Signatures of negative and positive selection were also detected in
PPP1R2P9, further suggesting a role as a functional protein.
Conclusions: The results show that contrary to initial observations PPP1R2-related pseudogenes are not simple
bystanders of the evolutionary process but may rather be at the origin of genes with novel functions.
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In the past, pseudogenes were generally regarded as func-
tionally inert, due to the presence of several disabling fea-
tures that prevent their expression (e.g. premature stop
codons, frameshift mutations, no promoter regions, etc.),
and therefore their evolution has been considered to be
neutral [1]. However, this view has been challenged by new
evidences, which demonstrate that certain pseudogenes are
functionally active [1,2]. The GENCODE, a sub-project of
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estimated the number of pseudogenes in the human gen-
ome to be near 14,000 [3]. From these, ~6% were identified
has potentially transcribed by computational models and al-
most half of them validated by RT-PCR-Seq techniques [3].
Indeed, pseudogenes can be functional at the DNA, RNA
or protein levels and have a function related or independent
of the parental gene [4]. At the DNA level, pseudogenes
can regulate other genes by pseudogene insertion in the
non-coding or coding region of the target gene and regulate
the parental counterpart gene by gene conversion, homolo-
gous recombination and through regulatory sequences [4].
Concerning the RNA level, pseudogene RNAs can compete
with the parental mRNA for miRNAs, RNA binding pro-
teins and/or translational machinery binding, as well as,
functioning as siRNAs and thereby inhibiting the parentald Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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lated genes as long non-coding RNAs, by encoding miRNA
precursors or even compete for miRNAs [4]. At the protein
level, pseudogenic proteins can have the same activity of
the parental protein but function in different tissues,
subcellular localization and/or pathophysiological condi-
tions [5-11]. Pseudogenic proteins with altered functions
might also affect the activity of the parental ones [12]. If a
pseudogene mRNA is translated to a functional pseudo-
genic protein, this gene is often called a retrogene [13].
Pseudogenes can also produce truncated proteins that can
function as antigenic peptides in the surface of the cells to
stimulate the immune system against the malignant cells
[4]. Pseudogenes have already been associated with several
pathological conditions such as cancer [4], diabetes [14]
and neurodegenerative diseases [15].
One promising model to understand the functional
relevance of pseudogenization is the protein phosphatase
1 regulatory subunit 2 (PPP1R2). This protein, also known
as inhibitor-2 (I2), was one of the first regulatory subunits
identified as an inhibitor and binding partner of the
Ser/Thr phosphoprotein phosphatase 1 (PPP1). PPP1R2
forms a stable complex with PPP1 catalytic subunit
(PPP1C) blocking the active site and inhibiting it potently,
being the reactivation triggered by phosphorylation [16-21].
The PPP1C/PPP1R2 complex has been implied in sev-
eral processes such as cardiac function [22-24], mitosis
and meiosis [25-30], tubulin acetylation and neuronal
cell survival [31]. Also, it has been previously shown
that a PPP1CC2/PPP1R2-like complex is important in
the acquisition of sperm motility [32,33].
The PPP1R2 gene is conserved throughout all eukaryotes,
from yeast to humans, with homologues found even in
plants [34,35]. In the human genome, as observed for
other ancient PPP1 inhibitors such as PPP1R8 (NIPP1)
and PPP1R11 (I3), several sequences have been identified
that are highly similar to PPP1R2 [34]. For PPP1R2, nine
loci were found that present hallmark features of processed
pseudogenes. These related sequences were collectively
named PPP1R2 pseudogenes and were numbered from
1 to 9 (PPP1R2P1-P9) [34]. These pseudogenes are found
scattered in the genome due to random retrotransposition
phenomena that consist on the reverse transcription of
cellular RNAs and random insertion into the nuclear gen-
ome [36,37]. Past studies identified four PPP1R2 pseudo-
genes at the messenger RNA level using high throughput
techniques. PPP1R2P1 and PPP1R2P2 were discovered in
human [38,39], PPP1R2P3 in human and crab-eating ma-
caque (Macaca fascicularis) and PPP1R2P9 (also called I4)
was found in human and mouse (Mus musculus) [40-43].
In this work we performed an exhaustive search for
PPP1R2 pseudogenes in publicly available mammalian
genome databases in order to infer their evolutionary
history. In the collected pseudogenes, an assay for detectionof the proteins was conducted. Our results show that
evolution and pseudogenization of PPP1R2 gene may
be correlated with the formation of new genes and the
gain of new specific functions.
Results and discussion
A total of 119 sequences were retrieved from the NCBI and
Ensembl databases by blasting against the human PPP1R2
mRNA sequence. Ten pseudogenes were obtained from
human sequences, increasing by one the previous number
reported in the literature [34]. All pseudogenes obtained
are intronless and with a truncated 5’UTR meaning that
are processed pseudogenes. The parental human PPP1R2
CDS (618 bp) covers 17% of the entire mRNA (3475 bp);
even the pseudogenes with the lowest coverage contain
the parental CDS, with the exception of PPP1R2P7 that
only comprises part of the 3’UTR.
Phylogenetic analysis
In order to increase the reliability of the alignment for
the phylogenetic reconstruction, we selected sequences
with >85% coverage and >60% similarity with the human
PPP1R2 CDS. By doing this, 81 sequences were included
in the tree that represented all the pseudogenes with the
exception of PPP1R2P7 (Additional file 1: Table S1). The
unused sequences encompassed pseudogenic fragments
and sequences where identity with PPP1R2 was detected
mostly outside the CDS (e.g. PPP1R2P7) or presented trun-
cated CDS (e.g. some PPP1R2P8 and PPP1R2P9).
From the ML tree, four major clusters can be distin-
guished, generally supported by high bootstrap values
(Figure 1). One of the clusters includes most mam-
malian PPP1R2 sequences, the exceptions being Pri-
mates PPP1R2, Glires PPP1R2, PPP1R2-like sequences
(rabbit, Oryctolagus cuniculus, Orcu; rat, Rattus norvegicus,
Rano; and mouse, Mus musculus, Mumu), and the elephant
PPP1R2 (Loxodonta africana, Loaf). The other cluster com-
prises PPP1R2P8 and PPP1R2P8-like primate sequences.
Mammalian PPP1R2P9 sequences compose a third cluster
and a fourth cluster includes all PPP1R2 and related pseudo-
gene sequences from Primates (PPP1R2P1/P2/P3/P4/P5/P6/
P10). These sequences are clustered with the Glires PPP1R2
sequences. PPP1R2 is also present in the gray short-tailed
opossum (Monodelphis domestica, Modo) which is consist-
ent with the presence of PPP1R2 in eukaryotes, being indeed
an ancient and well conserved gene [34].
Two major retroposition events can be inferred, the
retroposition that originated PPP1R2P9 and the retro-
position that gave origin to PPP1R2P1/P2/P3/P4/P5/P6/
P10 (Figure 2). Retroposition of PPP1R2P9 occurred before
the split of Eutheria (placental mammals) from Metatheria
(marsupial mammals) at ~163.9-167.4 millions of years ago
(Mya), as suggested by the presence of this pseudogene in
the marsupial gray short-tailed opossum and in all other
Figure 1 Evolutionary tree of PPP1R2 and related pseudogenes. The evolutionary history was inferred using the software GARLI. Best ML
tree found in 1000000 generations is shown. Bootstrap values from 1000 replicates appear next to the nodes with values below 50% not shown.
Group clusters are presented on the right, R2: PPP1R2 group; P1-P9: PPP1R2P1-P9 group. Low case letters before groups, p: primates; m: mammals;
g: glires. Each sequence included in the tree is denoted by the first two letters of the genera followed by the first two letters of the species
description and by the name of the gene same way as for the groups, Aime: Ailuropoda melanoleuca; Bota: Bos taurus; Cafa: Canis familiaris; Caja:
Callithrix jacchus; Chae: Chlorocebus aethiops; Eqca: Equus caballus; Gogo: Gorilla gorilla; Hosa: Homo sapiens; Loaf: Loxodonta africana; Mado:
Monodelphis domestica; Mamu: Macaca mulatta; Mumu: Mus musculus; Nole: Nomascus leucogenys; Orcu: Oryctolagus cuniculus; Patr: Pan troglodytes;
Poab: Pongo abelii; Rano: Rattus norvegicus; Susc: Sus scrofa.
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still present in humans (Figure 2). In the X chromosome
we found, close to PPP1R2P9, more PPP1R2-like copies
that seem to have arisen by PPP1R2 gene duplication: mar-
moset (one copy), rat (two copies), mouse (two copies) and
pig (one copy). The phylogenetic analysis shows that these
copies are related to parental PPP1R2 gene suggesting that
this gene has been retroposed to the X chromosome more
than once independently and at different time points in
these species. We checked for gene conversion events and
we did not find any evidence for it. In the phylogenetic tree
the PPP1R2P9 genes are clearly apart of these PPP1R2-like
that are clustered in the PPP1R2 gene group. PPP1R2P7 is
also non-primate specific. Indeed, PPP1R2P7 was present
in all mammalian orders included in this study, with the
exception of Glires and opossum, suggesting that it was
originated ~94.4-163.9 Mya (Figure 2). Retroposition
of PPP1R2P1/P2/P3/P4/P5/P6/P10 is more recent and
occurred in the ancestor of Primates and during Pri-
mates’ evolution since these pseudogenes occur only in
primate species (Figure 2). Other retroposition events
of PPP1R2 gene have also occurred in some mammals
(pig, Sus scrofa, Susc; dog, Canis lupus familiaris, Cafa;
giant panda, Ailuropoda melanoleuca, Aime; marmoset,Callithrix jacchus, Caja; and mouse; shown in the tree
as R2-like) and appear to be species-specific events
since these fragments are not widespread in mammals
and both copies present in each species cluster together.
Clustering of Glires PPP1R2 and R2-like pseudogenes
along with PPP1R2P1/P2/P3/P5/P6/P10/P4 from Primates
is consistent with the grouping of these species within
the Euarchontoglires (or Supraprimates) superorder [44].
PPP1R2P1 was originated before the separation of New
World monkeys (Platyrrhini) and Catarrhini that occurred
43.4-65.2 Mya (Figure 2). A 70 bp deletion seems to
have occurred in Hominidae after the divergence from
Hylobatidae, ~20.6 Mya. Also, an Alu repeat was inserted
after the radiation of the Hominoidea, ~29.4 Mya, in the
middle of the sequence disrupting it, but without affecting
the open reading frame (ORF) (Figure 3). Interestingly, in
chimpanzee, PPP1R2P1 suffered a recent duplication event
that gave rise to a second locus separated by two Alu re-
peats flanking a LINE1 (long interspersed nuclear element,
family L1) element (Figure 3, not included in the ML tree).
Concerning PPP1R2P3, we found that it clusters along
with Primates’ PPP1R2 suggesting that this is the most
recent retroposed pseudogene originated after the separ-
ation of Hominoidea from Cercopithecoidea (old world
Figure 2 Diagram of PPP1R2 pseudogenes evolution. Time scale from the early mammals evolution till humans is shown with emphasis in
the primate class. The time in million years ago (Mya) indicates the split between groups. Pseudogenes estimated emergence is shown, as well
as, important retrotransposable elements.
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rhesus monkey and marmoset (Figures 2 and 3). Clustering
of PPP1R2P2 and PPP1R2P10/P4 might indicate that these
pseudogenes arose by duplication. Our analysis shows that
PPP1R2P10 is the ancestral, being originated before
the division of Platyrrhini and Catarrhini (42.6-65.2 Mya),
while PPP1R2P4 is a duplication that occurred onlyFigure 3 Conserved linkage of PPP1R2P1 and PPP1R2P3. PPP1R2P1 an
presented concerning each species where were found, showing the conse
number flanking the pseudogenes is related to the parental PPP1R2 messa
repeats that are primate-specific. Grey boxes refer to the long interspersed
boxes indicates the location where the repeat interrupted the sequence. In
originated and the repeats are located in the middle of both, and so, the n
the other. Also, a deletion is shown (129 to 194) that is common to all pse
(3186 to 3295) also occurred in rhesus monkey. TAP1: transporter 1, ATP-bi
complex, class II, DM beta; SGCD: sarcoglycan delta; TIMD4: T-cell immunogin humans, being therefore a duplicated pseudogene
(Figures 1, 2 and 4). Also, in orangutan, a duplication
occurred very close to PPP1R2P10 (~8.8 kb) that is not
related with human PPP1R2P4, and was hence here named
PPP1R2P10-like (Figures 1 and 4). The other pseudogenes
(PPP1R2P5, PPP1R2P6 and PPP1R2P8) were originated
at the same time as PPP1R2P10 (Figures 2, 4 and 5).d PPP1R2P3 location in terms of chromosome and flanking genes is
rved linkage. Divergence time is shown on the left. The nucleotide
ge. Black boxes refer to the short interspersed elements (SINEs) Alu
elements (LINEs), in this case a LINE1 element. Number above the
the case of chimpanzee PPP1R2P1, a duplicated pseudogene was
umbers refer to the final of one pseudogene and the beginning of
udogenes with the exception of gibbon and marmoset and a deletion
nding cassette, sub-family B; HLA-DMB: major histocompatibility
lobulin and mucin domain containing 4.
Figure 4 Conserved linkage of PPP1R2P2, PPP1R2P10/4, PPP1R2P5 and PPP1R2P6. PPP1R2P2, PPP1R2P10/4, PPP1R2P5 and PPP1R2P6
location in terms of chromosome and flanking genes is presented concerning each species where were found, to show the conserved linkage in
these pseudogenes. Divergence time is shown on the left. The nucleotide number flanking the pseudogenes is related to the parental PPP1R2
message. Black boxes refer Alu repeats that are primate-specific. Number above the boxes indicates the location where the repeat interrupted the
sequence. Grey box delimited with a black line in rhesus monkey PPP1R2P5 refer to a parental PPP1R2 insertion. Number on the top indicates
where the insertion took place in the pseudogene, while numbers at the bottom show which region of the parental PPP1R2 was inserted. In
orangutan an unknown sequence according to the current genome assembly was inserted in PPP1R10-like and is shown with a number on the
bottom referring to the location. Gibbon PPP1R2P10 sequence was retrieved in a portion of the chromosome 5 not properly localized in the
reference genomic sequence and so, even if the flanking genes were present in the same chromosome, the local could not be verified. The
distances in dashed lines of the duplicated forms in human and orangutan are also indicated. RUNX1: Runt-related transcription factor 1; SETD4:
SET domain containing 4; PCDH9/20: protocadherin 9/20; ST6GAL2: ST6 beta-galactosamide alpha-2,6-sialyltransferase 2; SLC5A7: solute carrier
family 5 (choline transporter), member 7; JHDM1D: histone demethylase 1 homolog D; SLC37A3: solute carrier family 37 (glycerol-3-phosphate
transporter), member 3.
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from the Platyrrhini ~29.2-42.6 Mya (Figures 2 and 4). The
PPP1R2P7 (Glires) and PPP1R2P8 (gibbon) sequences were
not retrieved from the databases, which suggest the later
deletion of these pseudogenes (Figure 5). The fact that
some genome annotations are early assemblies, might
explain the missing of these and other sequences. However,
the good quality of Glires (Mus, Rattus and Oryctolagus)
genome assemblies reinforces the absence of PPP1R2P7
sequence and suggests that it occurred in the common
ancestor. The absence of gibbon PPP1R2P8 sequence
could also be explained by the several insertions present,
similar to what happens in other species, virtually dis-
mantling it and making the retrieval impossible (Figure 5).
Moreover, the conserved linkage confirms the results of
the phylogenetic analysis, being all pseudogenes flanked
by the same respective genes in all species analyzed
(Figures 3, 4, 5, 6).Evidences for functionality of PPP1R2-related pseudogenes
Features such as the existence of transcriptional related
data, presence of regulatory elements, mRNA stability
(e.g. UTRs, polyA signals), translation initiator sequence
and complete ORFs (no truncations or disabling mutations)
are indicators of the putative functionality of genes. A
search for such features was conducted in order to verify
the potential functionality of the PPP1R2 pseudogenes.
PPP1R2P1
The Gene Expression Omnibus (GEO, NCBI) and Gene
Expression Atlas (GXA, Ensembl) public repositories
contain expression data for PPP1R2P1. The presence
of promoters, enhancers and other regulatory elements
could be an explanation for PPP1R2P1 transcriptional
related data (174 GEO and 2 GXA), although basal
transcription should not be set aside. Concerning the
mRNA stability, only part of the 5’UTR (238 bp), due to
Figure 5 Conserved linkage of PPP1R2P7 and PPP1R2P8. PPP1R2P7 and PPP1R2P8 location in terms of chromosome and flanking genes is
presented concerning each species where were found, showing the conserved linkage. Divergence time is shown on the left. The nucleotide
number flanking the pseudogenes is related to the parental PPP1R2 message. Grey boxes refer to the long interspersed elements most LINE1
elements and one LINE2 element. Black boxes indicate SINEs most Alu repeats that are primate-specific but also others (e.g. MIR). Checkered box
indicate long terminal repeat (LTR, from the ERV1, ERVL and MaLR families). Black diagonal traced white boxes indicate DNA-related repeats
(hAT-Charlie and TcMar-Tigger families). Number above the boxes states the location where the repeat interrupted the sequence. Numbers inside
the boxes indicate if there is more than one in line. White boxes delimited with a black line show a region that is absent and substituted by other
unknown region. Numbers below the boxes show the region that is absent. * part of this sequence has unknown nucleotides and so the range
(2558-3203 bp) might be similar to the other species (2843-3203 bp).
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part of the 3’UTR (506 bp) are present. Therefore, the
stability might be compromised although a polyA sig-
nal (ATTAAA) is present near the 3’UTR terminus
(position 1361, Figure 3). Regarding the translation, the
Kozak sequence, important for translation initiation, is
present in the parental gene and is conserved in PPP1R2P1.
Altogether, these results suggest that at least in humans,
PPP1R2P1 is expressed and might be functionally relevant.
Although we cannot set aside the low quality of someof the assembled genomes, in other primates the ORF
of PPP1R2P1 has frameshift disruptions that introduce
premature stop codons, indicating that in these species
might not produce a putative functional protein, or if
so the protein might be truncated.
PPP1R2P3
The sequence of PPP1R2P3 is complete, without any
frameshifts or element repeats disruptions (Figure 3). The
sequence was truncated at the 5’UTR, as expected due to
Figure 6 Conserved linkage of PPP1R2P9. PPP1R2P9 location in terms of chromosome and flanking genes is presented concerning each
species where was found, showing the conserved linkage. Divergence time is shown on the left. The nucleotide number flanking the
pseudogenes is related to the parental PPP1R2 message. Grey boxes refer to the LINE1 elements. Black boxes refer to SINEs B2 repeats that are
rodent-specific and to the tRNAs present in the horse (Equus caballus) and in the giant panda sequences. Checkered box refers to long terminal
repeat (LTR) in the giant panda sequence, which is an endogenous retroviral-related element (ERVL). Number above the boxes states the location
where the repeat interrupted the sequence. Numbers inside the boxes indicate if there is more than one in line. Grey box delimited with a black
line in marmoset PPP1R2P9-like refer to a parental PPP1R2 insertion. Number on the top refers where the insertion took place in the pseudogene,
while numbers at the bottom show which region of the parental PPP1R2 was inserted. In mouse an unknown sequence according to the current
genome assembly was inserted in PPP1R2P9-like and is shown with a number referring to its location. Also, a deletion is shown in mouse
(1067 to 1373) and in rat (1065 to 1373) PPP1R2P9-like pseudogenes. The distances in dashed lines of the other retroposed forms in marmoset,
mouse, rat and pig are also indicated. CASK: calcium/calmodulin-dependent serine protein kinase; MAOA: monoamine oxidase A.
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3’UTR it lost two of the four polyA signals that may lead to
a short ~1500-1600 nt message. We have previously found,
by a yeast two hybrid screening of human testis cDNA,
using as bait PPP1CC1, one clone assigned to PPP1R2P3
[43,45]. A search for PPP1R2P3 ESTs in databases revealed
that this is one of the most represented PPP1R2 pseudo-
genes (72 GEO, 313 GXA), being highly detected in testis
(14 ESTs in Unigene). Together with our previous data, this
strongly suggests that this pseudogene is transcribed. Two
independent reports using mass spectrometry have also
assigned peptides to PPP1R2P3 [46,47]. However, these
peptides share the sequence with both parental gene and
PPP1R2P3, being most probably misassigned. Nonetheless,
we have shown recently by mass spectrometry the presence
of PPP1R2P3 in human sperm samples [48].
PPP1R2P9
The PPP1R2P9 sequences retrieved have not been dis-
rupted, at least in primates (Figure 6). However, the
5’UTR of the parental gene is absent and the 3’UTR is
truncated (671 bp in humans). At the 3’UTR there is a
single polyA signal at nucleotide position 1088, according
to the human sequence, which suggests that a shorter
message is produced. Sequence repeats, deletions, unknown
and known sequence insertions were only found in the
PPP1R2-like sequences (Figure 6). The only exceptions
are in mouse and rat where the 3’UTR was deleted in
the parental PPP1R2P9 (Figure 6).
This pseudogene is the one with more transcriptional
related data (1086 GEO, 128 GXA) and has many ESTs
in testis (9 ESTs in Unigene) like PPP1R2P3. PPP1R2P9
was originally found in cDNA libraries of human germ
cell tumors, binding to PPP1C directly and in heat stable
extracts inhibits this phosphatase potently with an IC50 of
0.2nM [40]. Also, we have recently identified PPP1R2P9
as an interacting partner of PPP1CA by yeast-two hybrid
in human brain [49]. This suggests that silent regulatory
areas are present in the region were PPP1R2P9 was retro-
posed and that during the evolution PPP1R2P9 might
have retained or gained the capacity to be transcribed.
In spite of this, there is no data suggesting the transla-
tion of PPP1R2P9. Considering the ORF, all species
show a continuous ORF with no or small truncations at
the C-terminus (e.g. in mouse and rat), with the excep-
tion of pig where no protein translation was obtained
from the ORF.
Evidences of non-coding nature of PPP1R2-related
pseudogenes
Considering the other pseudogenes sequences, many inser-
tions in PPP1R2P8 lead to a completely disrupted ORF and
missense mutations in PPP1R2P4/P10 and PPP1R2P6 lead
to premature stop codons (Figures 4 and 5). Also, sincethese pseudogenes showed low coverage to the parental
gene, most of the 3’UTR is missing and so, regulatory
elements such as polyadenylation signals that are import-
ant for the transcript cleavage and stability are absent.
This indicates that no transcription or translation should
be expected from these pseudogenes, which corroborates
with the fact that no expression was found in ESTs and
high-throughput databases with the exception of PPP1R2P4.
Considering the pseudogenes with the highest coverage in
relation to the parental gene, PPP1R2P2 and PPP1R2P5,
no ORF disruptions were found but many missense
mutations were found in all species analyzed that lead
to premature stop codons (Figure 4). All four polyade-
nylation signals present in the parental PPP1R2 mRNA
are conserved in PPP1R2P2. Although protein expression is
unlikely, PPP1R2P2 message was found by qPCR in human
testis but not in peripheral blood leukocytes [39]. Also, two
experiments from ArrayExpress, report the up/down
regulation of this pseudogene in prostate adenocarcin-
oma and in a prostate transcriptomic study performed
in a Caucasian population [50]. These results might be
artifacts or could be due to other PPP1R2 pseudo-
genes/parental gene since this pseudogene is located in
chromosome 21 that has low density (~232 genes, only
surpassed by the Y chromosome with 130 genes), and
as expected, the processed pseudogene density is also
low, 34 [51], making the transcription highly unlikely.
Detection of PPP1R2-related proteins
PPP1R2 forms a stable and high affinity complex with
PPP1C by blocking the active site. The reactivation of
the complex is triggered by phosphorylation at Thr72
of PPP1R2 through several kinases, including glycogen
synthase 3 (GSK3) [52-54]. PPP1R2 is also phosphorylated
at the residue Ser86 by casein kinase 2 (CK2) that acceler-
ates the subsequent phosphorylation at Thr72 by GSK3
[16]. The comparison of human PPP1R2P1, PPP1R2P3
and PPP1R2P9 with PPP1R2 amino acid sequences
(Figure 7) shows that PPP1R2P9 is the most divergent
(41%) and PPP1R2P3 the most similar (95%). Regarding
the PPP1 binding motifs, SILK and KSQKW, they are
conserved in all PPP1R2-related proteins, and KLHY is
conserved in PPP1R2P3 but a substitution of the first
residue to Thr or Arg is observed for PPP1R2P1 or
PPP1R2P9, respectively [55]. The C-terminal acidic stretch
(DDDEDEE) required for GSK3 phosphorylation [55,56] is
maintained in PPP1R2P3 although the GSK3 phos-
phorylation site Thr73 is substituted to Pro. The other
two pseudogenes maintain the GSK3 phosphorylation
site but the acidic stretch has several changes particularly
in PPP1R2P9 (Figure 7). Finally, the CK2 phosphorylation
site Ser87 is conserved in PPP1R2P1 but is substituted by an
Arg in PPP1R2P3 and PPP1R2P9. Overall, the analysis
shows that these PPP1R2-related proteins should maintain
Figure 7 Alignment of PPP1R2-related proteins reveals high conservation. An alignment was performed using the protein sequences
of PPP1R2P1, PPP1R2P3, PPP1R2P9 and PPP1R2. Black arrows indicate the important phosphorylation sites in PPP1R2 and the respective
known kinase. Black boxes encage each PPP1 binding motif known for PPP1R2 and the acidic stretch. Black bars at the bottom of each row
of alignment show the region covered by the peptides obtained. Two-headed arrow indicates the peptide for which the antibody used for
immunoprecipitation was raised. * represent high conservation, : and . represent low conservation in which the substituted residue has
respectively more or less similar properties.
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strated for PPP1R2P3 and PPP1R2P9 [40,48], and the
ability to regulate the holoenzyme activity by GSK3
phosphorylation is compromised in PPP1R2P3 [48], and
may also be but in a lesser extent in PPP1R2P9, due to the
change Ser87 to Arg.
PPP1CC2 is a sperm-specific protein phosphatase
involved in spermatogenesis and sperm motility [32,33,57].
Its inhibition in vivo, was associated with a PPP1R2-like
activity since GSK3 was able to reverse the process
[32]. Recently, a report identified the PPP1R2 protein
in heat-stable extracts of bull testis and mouse testis
and sperm where it may account for this PPP1R2-like
activity [58]. It is well known that testis is one of the
organs where most pseudogenes are expressed and their
gene products were shown to have important roles in
spermatogenesis and other germ cell related functions
[52-54]. This might be due, in part, to the hyper-
transcription state of the autosomal chromosomes in
the meiotic and post-meiotic germ cells due to chro-
matin modifications [13,54,59]. A recent study done by
GENCODE has revealed that 64% of all validated expressed
pseudogenes are expressed in testis [3]. PPP1R2 is one
of the PPP1C regulators with more related pseudogenes
[34]. We have previously identified PPP1R2P3 message
and protein, in testis [43,45,48]. We hypothesized that from
the other pseudogenes, only PPP1R2P1 and PPP1R2P9 are
capable of being also translated. In fact, the two pseudo-
genes, PPP1R2P3 and PPP1R2P9, were present in the massspectrometry data obtained from a human sperm immuno-
precipitation (Table 1).
This analysis was based on the fact that the molecular
weight of these PPP1R2-related proteins should be similar
to the parental one (PPP1R2-23.0kDa), being therefore
present in the same region where the band was extracted to
mass spectrometry analysis. The antibody used to immuno-
precipitate PPP1R2-related proteins was raised against a
peptide containing amino acid residues 134–147 from
the mouse PPP1R2 sequence (Figure 7). This antibody was
used previously to detect PPP1R2 [48,58]. In the 14-residue
region, PPP1R2P1 and PPP1R2P9 have two and three
substitutions respectively, when comparing to PPP1R2
sequence. We predicted that using this antibody, we
were also able to detect the other PPP1R2-related proteins.
Mass spectrometry data identified 23 MSMS (tandem mass
spectrometry) spectra corresponding to 8 different peptides
matching unequivocally to PPP1R2P9 (Figure 7 and Table 1)
and 3 MSMS spectra corresponding to one peptide match-
ing unequivocally to PPP1R2P3 [48].
The sequence coverage obtained for PPP1R2P9 was
36.5% and the mascot score levels were 623.41 (in
addition, spectra were manually evaluated). This is the
first time that PPP1R2P9 protein is detected, being
clearly recovered from human ejaculated sperm. Addition-
ally, these results also indicate that native PPP1R2-related
proteins are indeed heat stable and migrate at the same
position as the parental PPP1R2. Lastly, no peptides were
recovered for PPP1R2P1 using this method, which might
Table 1 PPP1R2P9 presence in human sperm
Protein name Uniprot ID MW (Da) pI Protein size (aa) Coverage Mascot score
PPP1R2P9 IPP4_HUMAN 22,660 5.04 202 36.5% 623.41
Peptide Range (start-end) Number of spectra m/z meas. z Mascot score
K.NKSSSGSSVATSGQQSGGTIQDVK.R 17–40 6 770.71 3 21.95
K.SSSGSSVATSGQQSGGTIQDVK.R 19–40 6 1,034.49 2 99.44
K.SSSGSSVATSGQQSGGTIQDVKR.K 19–41 4 1,112.54 2 38.09
R.LHYNEELNIK.L 143–152 2 424.89 3 31.40
K.ANEPGTSYMSVQDNGEDSVRDVEGEDSVR.G 68–96 2 1,053.45 3 63.05
R.RLHYNEELNIK.L 142–152 1 476.92 3 29.73
R.ATYRDYDLMK.A 58–67 1 431.20 3 28.17
K.ANEPGTSYMSVQDNGEDSVR.D 68–87 1 1,086.46 2 69.26
Peptides were identified by Orbitrap Velos mass spectrometry, from human sperm heat stable extracts and immunoprecipitates using rabbit anti-PPP1R2
antibodies. aa, amino acids; pI, isoelectric point.
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sperm cells.
Signatures of selection
Pseudogenes have been regarded as being derived from
functional-encoding genomic DNA sequences that have ac-
cumulated disabling mutations (frameshifts and premature
stop codons) that make them non-coding protein genes.
This lack of function predicts that pseudogenes are
not under selective pressures and thus evolve neutrally
(reviewed in [1]). Nevertheless, this view keeps being
challenged by the accumulation of examples of tran-
scribed pseudogenes with several acknowledged functions
(e.g. regulation of the expression of paralogous genes
through the generation of small-interfering RNAs) [1].
Signatures of selection, in addition to sequence conser-
vation, have been considered as obvious indicators of
the functional importance of pseudogenes [60].
Here, by using six ML methods, signatures of both
positive and negative selection were detected in the
PPP1R2P9 pseudogene, as well as in the parental gene
PPP1R2 (Additional file 2: Table S2). Signatures of
negative selection were far more evident than those of
positive selection, for both genes. Four methods, REL,
FEL, SLAC and FUBAR, showed sites negatively selected,
with most being detected by more than one method.
Signatures of positive selection were principally detected
by FEL and MEME methods. The codons 92 and 120, for
PPP1R2, and the codons 6, 208 and 211, for PPP1R2P9,
were detected by at least two separate methods. No detec-
tion was obtained for the PAML method. It is known that
sperm-expressed genes present in chromosome X tend to
be positively selected when compared with X-linked non-
sperm genes and with sperm-expressed autosomal genes
[61,62]. This evolutionary pressure is due to their hemizi-
gous expression in males that will favor advantageous mu-
tations and remove any deleterious one. PPP1R2P9 is notevolving neutrally and may thus be expressed, further
supporting a functional role for this pseudogene.
Conclusions
Retropositions from the PPP1R2 gene are ancient, prior
to the great radiation of the mammals, as supported by
the presence of PPP1R2P9 and PPP1R2P7 in the different
groups of mammals. All the other pseudogenes found in
humans are primate-specific and were retroposed at differ-
ent times during the evolution of this group. For instance,
PPP1R2P3 exists only in the members of the Hominoidea
family, whereas PPP1R2P8, the most distinct, is present in
all groups and was retroposed ~42.6-65.2 Mya. This reveals
that retropositions have occurred in waves and in a unique
way similar to the Alu repeats explosion that occurred ~40-
50 Mya, after the divergence of simian ancestors from
the prosimians (lemurs and lorises). The recent pseudogene
duplication in humans, PPP1R2P4, and in chimpanzee,
PPP1R2P1, suggests that evolution of pseudogenes is still
an active process.
As suggested by the presence of an uninterrupted ORF,
ESTs and polyA signals, PPP1R2P9 (along with PPP1R2P1
and PPP1R2P3) appears to be transcribed. Moreover, the
finding of positive and negative selection signatures
suggests that it could be functionally relevant. Indeed,
we confirmed that two PPP1R2-related proteins are trans-
lated in human sperm (PPP1R2P3 and PPP1R2P9), and are
heat stable in their native form [48]. The importance of
these PPP1R2-related proteins in physiological conditions,
such as spermatogenesis and sperm physiology, should
be assessed in future studies. Besides this, PPP1R2P1,
PPP1R2P3 and PPP1R2P9 were found to be associated
with pathological conditions [15,38,40,42,63]. Thus, asses-
sing their ratios may be considered as a diagnostic tool
in the future.
Furthermore, it has been shown that pseudogenes can
regulate their parental counterparts at the RNA level either
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bilizing factors and miRNAs [64]. Although PPP1R2P2,
PPP1R2P4 and PPP1R2P10 translation is very unlikely,
their expression is documented and so, it is feasible these
pseudogenes could regulate the parental PPP1R2 message
levels and therefore its function.
These observations indicate that PPP1R2 pseudogenes
have possible biological functions rather than acting as
non-functional relics as initially believed. Their evolution
process might be in part related with the formation of new
genes and the gain of new specific functions. Therefore,
their designation as pseudogenes should be reevaluated.
Methods
Sequences retrieval
The human PPP1R2 mRNA sequence (GenBank accession
number NM_006241.4) was used to detect orthologs
and pseudogene-related sequences by performing a BLAST
search on GenBank, from National Center for Biotechnology
Information (NCBI, http://BLAST.ncbi.nlm.nih.gov/) and
Ensembl (http://www.ensembl.org/Multi/blastview) da-
tabases against all available mammalian reference gen-
omic sequences. Only sequences with more than 60% of
sequence similarity and with query coverage of more
than 35% were recovered. Genomic sequences flanking
the retrieved sequences were also manually inspected
for missing parts, especially at the 3’UTR.
Evolutionary tree reconstruction and divergence times
The retrieved sequences (Additional file 1: Table S1) were
visually inspected and aligned using ClustalW implemented
in BioEdit 7.0.9.0 [65]. For phylogenetic reconstruction, and
to improve accuracy, only sequences encompassing >85%
coverage of the human PPP1R2 CDS (nucleotide positions
377–994 of the mRNA sequence) and with >60% of se-
quence similarity were included in the alignment. In order
to determine the phylogenetic relationships between
the PPP1R2 gene and related pseudogenes, the best-fit
model of nucleotide substitution was first assessed using
the program jModelTest v0.1.1 [66] under the Akaike
Information Criterion (AIC). A maximum likelihood (ML)
phylogeny was inferred using the software GARLI v1.0
[67] by indicating the best nucleotide substitution model.
No starting topology was defined and the program was
set to run until no significant topology improvement
(as defined by the default settings) was found after
1000000 generations. Five independent runs were per-
formed to check the consistency of the estimates. The
support of each node was assessed using 1000 bootstrap
replicates. For each bootstrap replicate, the number of gen-
erations was set at 100000, above the generation where the
last topological improvements were found for each of the
five independent replicates. A 50% majority-rule consensus
tree of the 1000 bootstrap replicates was created usingPAUP* [68]. The support values at each node of the con-
sensus tree were added to the best tree found by GARLI.
Divergence times from the other species in relation to
Homo sapiens in millions of years ago (Mya) were obtained
from TimeTree (http://www.timetree.org/) [69].
Pseudogene classification and conserved linkage
Sequences obtained from the BLAST queries were analyzed
in terms of presence of intronic regions, polyA traits
(PolyApred, http://www.imtech.res.in/raghava/polyapred/),
truncation of the 5’UTR and chromosomal location.
Chromosomal locations were obtained from the GenBank
database (Additional file 1: Table S1). Pseudogenes located
in the same chromosome and nearby and/or with intronic
regions were classified as duplicated pseudogenes. Pseudo-
genes that were located in different chromosomes and had
polyA traits, truncation of the 5’UTR and no introns were
classified as processed pseudogenes. Furthermore, genes
flanking each human PPP1R2 pseudogene and conserved
among mammals were selected. Conserved linkage, mean-
ing conservation of synteny and also conservation of the
gene order, was then searched for in order to provide
insights regarding their orthology.
Distance to closest and repeated regions
The distance of each pseudogene to the closest neighboring
gene, not taking into account the presence of nearby pseu-
dogenes, was calculated. Repeated sequences were detected
by submitting each pseudogene sequence to the program
RepeatMasker from Institute for Systems Biology, Seattle,
Washington, USA (http://www.repeatmasker.org/).
Signatures of natural selection
Coding sequences evolving neutrally present a ratio (ω) of
non-synonymous (dN) over synonymous substitutions (dS)
that do not significantly deviate from one. An excess of
non-synonymous substitutions over synonymous substitu-
tions (dN > dS) might indicate positive selection, suggesting
that the replacement might be advantageous, while negative
selection results from the scarcity of non-synonymous sub-
stitutions (dN < dS), indicating that a particular mutation
most likely is deleterious and is being removed from the
gene pool. Pseudogenes are considered to evolve neutrally
(reviewed in [1]).
Maximum-likelihood codon-based tests were used to test
for statistically significant signatures of selection in PPP1R2
and related-pseudogenes. Nevertheless, only PPP1R2P9
sequences were analyzed since at least 10 sequences are
required to robustly detect signatures of selection [70].
Signatures of positive and negative selection were searched
for in Datamonkey webserver (http://www.datamonkey.org)
that uses the HyPhy package [71]. The best-fitting nucleo-
tide model (GTR +G) was determined using the automated
tool provided by Datamonkey. Five models were used:
Korrodi-Gregório et al. BMC Evolutionary Biology 2013, 13:242 Page 12 of 14
http://www.biomedcentral.com/1471-2148/13/242single likelihood ancestor counting (SLAC), fixed-effect
likelihood (FEL), random effect likelihood (REL), fast
unbiased bayesian approximation (FUBAR) and mixed
effects model of evolution (MEME). SLAC is based on
the reconstruction of the ancestral sequences and the
counts of dS and dN at each codon position of the
phylogeny. FEL estimates the ratio of dN/dS on a site-
by-site basis, without assuming an a priori distribution
across sites while REL fits a distribution of rates across
sites and then infers the substitution rate for individual
sites. FUBAR detects selection much faster than the
other methods and to leverage Bayesian MCMC to ro-
bustly account for parameter estimation errors. Finally,
MEME is capable of identifying instances of both epi-
sodic and pervasive positive selection at the level of an
individual site. Sites with P values <0.1 for SLAC, FEL
and MEME, posterior probability of >0.9 for FUBAR,
and Bayes Factor >50 for REL were considered as being
under selection. CODEML (PAML version 4, [72]) was
also used to detect positive selection by comparing a
null model and a model that allows positive selection
(M1 vs. M2 and M7 vs. M8). The contrasting models
were compared by computing twice the difference in
the natural logs of the likelihoods (2ΔlnL). In the site-
specific models that allow the ratio ω to vary among
codons, we performed Likelihood Ratio Tests (LRTs) with 2
degrees of freedom to compare the following models (NS
sites): M1 (nearly neutral evolution ω0 = 0, ω1 = 1) with M2
(neutral and positive selection: ω 0 = 0, ω 1 = 1, ω 2 > 1) and
M7 (beta-distributed negative selection: 0 # ω # 1) with M8
(beta-distributed negative selection and positive selection:
0 # ω1 # 1, ω2 >1) [2,73]. Only amino acids identified in
M8 by using the Bayes Empirical Bayes (BEB) approach
and with posterior probability >95% were considered as
evolving under positive selection. For the initial working
topology, ML trees were constructed using MEGA5 [74]
with substitution nucleotide models determined by the
software: TN93 + I and partial deletion (95% cut-off ) for
PPP1R2P9 and K2 + G with G = 4 and partial deletion
(95% cut-off ) for PPP1R2.
Sperm extracts and immunoprecipitation
Since testis is one of the organs where most pseudogenes
are expressed [75] and spermatozoa are the final product of
spermatogenesis, the presence of some of the studied pseu-
dogenes was tested in human sperm. Ejaculated sperm was
collected from healthy donors by masturbation into an
appropriate sterile container. Spermograms were performed
by experienced technicians and only samples with normal
parameters were used [76]. Informed consents were signed
allowing samples to be used for scientific purposes. The
study was conducted in accordance with the guidelines
of the “Helsinki Declaration”. In brief, sperm was lysed
in 1 × RIPA buffer (radioimmunoprecipitation buffer,Millipore Iberica S.A.U., Madrid, Spain) supplemented
with protease inhibitors (10 mM benzamidine, 1.5 μM
aprotinin, 5 μM pepstatin A, 2 μM leupeptin, 1mM PMSF),
sonicated 3 × 10 sec and centrifuged at 16000 g for 20min,
at 4°C. RIPA supernatant sperm extract was immunopre-
cipitated using Dynabeads® Protein G (Life Technologies
S.A., Madrid, Spain) and 1 μg of rabbit anti-PPP1R2
(against a mouse PPP1R2 peptide, amino acids 134–147)
with standard direct immunoprecipitation procedure [48].
Also, an independent RIPA supernatant sperm extract was
prepared, boiled in a water bath for 30 min, chilled on
ice for 2min and centrifuged at 16000 g for 20min, 4°C to
obtain a heat stable extract.
Mass spectrometry
For mass spectrometry analysis, the immunoprecipitate and
the heat stable extract were resolved by 10% SDS-PAGE
along with purified positive controls. Gels were stained
with Coomassie blue colloidal (Sigma-Aldrich Química,
S.A., Sintra, Portugal) using standard procedures [48].
Bands were then excised from the gel using commercial
PPP1R2 band as control and destained. An overnight diges-
tion with trypsin (Promega, Madison, Wisconsin, USA) was
performed and resulting peptides were extracted and
prepared for mass spectrometry analysis using an Orbitrap
Velos mass spectrometer as described elsewhere [48]. Sub-
sequent generated data were imported to ProteinScapeTM
(Bruker Daltonik GmbH, Bremen, Germany, [77]) and
analyzed using MASCOT (version 2.2.0, Matrix Science,
London, UK, [78]) search algorithm. Proteins were consid-
ered to be identified if the Mascot score (ProteinScapeTM)
was higher than 65.
Additional files
Additional file 1: Table S1. Nucleotide sequences used for the
alignments and evolutionary analysis.
Additional file 2: Table S2. PPP1R2 and PPP1R2P9 sites under negative
and positive selection revealed by 5 different methods using the
Datamonkey webserver.
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